Transmural Biotech

Towards a personalized, non-invasive,
accessible and efficient medicine.


Transmural Biotech is a spin-off of Hospital Clinic de Barcelona and Universitat de Barcelona created in late 2009 by medical and engineering professionals.
Our expertise draws on developing innovative medical technologies, mostly based on image analysis and processing, in order to provide health professionals with additional information beyond current diagnostic tools that can substantially improve the quality of the service offered to the patient.
The healthcare sector is compelled to undergo major modifications throughout the following years. The financial crisis has led to cheaper and more efficient solutions for clinical practice and, at the same time, the rise in life-expectancy and population ageing calls for a deep reassessment of the whole healthcare system.
Our aim is to develop innovative clinical products and services based on image analysis and processing techniques that make a personalized, non-invasive, accessible and efficient medicine possible. By doing this, we are following the current healthcare trends towards finding effective solutions to the current issues of this sector.
medicina nuevas tecnologias



Years of applying new technologies to the medical field have provided us with the expertise in identifying clinical needs and developing technological solutions and innovative business models that can adapt to every need:


  • Image analysis and processing
  • Artificial Intelligence
  • Machine Learning Algorithms
  • Data mining
  • Graphical User Interfaces (GUI’s)
  • Project coordination, planning and consulting


  • New fetal image analysis technologies
  • New non-invasive, fetal pathologies early diagnostic tools
  • Wide-range technologies that can apply to other medical fields such as neurodegenerative or cardiovascular diseases, among others


  • Identification and development of business models based on the application of new technologies such as the Internet to maximize accessibility and competitiveness of our products.

Commitment to Quality

Here at Transmural Biotech we are committed to delivering high-quality medical products and services to our customers so we continuously strive to improve in all aspects. This commitment is underscored by our EN ISO 13485 since 2012. The company is currently certified by IMQ.
Likewise, our market products bear the CE marking according to European Directive 93/42/EEC of Medical Supplies and the Amending Directive 2007/47/CE.

Our Partners

Throughout the past years, our projects have been greatly appreciated by several R+D+i public and private centers, which certifies the innovative quality of our solutions.
Additionally, we have forged several strategic alliances with world-renowned research centers and private companies that enable us to undertake new projects with confidence. Therefore, we are always on the lookout for new project opportunities and ventures. Please contact us at if you are interested in collaborating with us.
Clínic Barcelona
FEDER [Converted]